Labcorp Net Acquisitions/Divestitures 2010-2025 | LH
Labcorp annual/quarterly net acquisitions/divestitures history and growth rate from 2010 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
- Labcorp net acquisitions/divestitures for the quarter ending March 31, 2025 were $-0.054B, a 78.23% decline year-over-year.
- Labcorp net acquisitions/divestitures for the twelve months ending March 31, 2025 were $-1.895B, a 20.62% increase year-over-year.
- Labcorp annual net acquisitions/divestitures for 2024 were $-0.824B, a 22.7% increase from 2023.
- Labcorp annual net acquisitions/divestitures for 2023 were $-0.672B, a 42.23% decline from 2022.
- Labcorp annual net acquisitions/divestitures for 2022 were $-1.162B, a 133.93% increase from 2021.
Labcorp Annual Net Acquisitions/Divestitures
(Millions of US $) |
| 2024 |
$-824 |
| 2023 |
$-672 |
| 2022 |
$-1,162 |
| 2021 |
$-497 |
| 2020 |
$-268 |
| 2019 |
$-874 |
| 2018 |
$540 |
| 2017 |
$-1,883 |
| 2016 |
$-549 |
| 2015 |
$-3,736 |
| 2014 |
$-159 |
| 2013 |
$-160 |
| 2012 |
$-335 |
| 2011 |
$-138 |
| 2010 |
$-1,186 |
| 2009 |
$-216 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$20.885B |
$13.009B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
